IPC분류정보
국가/구분 |
United States(US) Patent
등록
|
국제특허분류(IPC7판) |
|
출원번호 |
US-0570831
(2005-08-16)
|
등록번호 |
US-8197427
(2012-06-12)
|
국제출원번호 |
PCT/US2005/029081
(2005-08-16)
|
§371/§102 date |
20061218
(20061218)
|
국제공개번호 |
WO2006/023481
(2006-03-02)
|
발명자
/ 주소 |
- Ward, Kevin R.
- Lenhardt, Martin L.
|
출원인 / 주소 |
- Virginia Commonwealth University
|
대리인 / 주소 |
Whitham Curtis Christofferosn & Cook, PC
|
인용정보 |
피인용 횟수 :
0 인용 특허 :
20 |
초록
▼
Acoustical-based methods that increase tissue oxygenation, and equipment for carrying out the methods, are provided. The methods involve exposing tissue to low frequency sound in order to increase blood flow in the tissue, and hence oxygenation of the tissue. The methods may be used to treat or prev
Acoustical-based methods that increase tissue oxygenation, and equipment for carrying out the methods, are provided. The methods involve exposing tissue to low frequency sound in order to increase blood flow in the tissue, and hence oxygenation of the tissue. The methods may be used to treat or prevent disorders related to ischemia and low blood flow, such as shock, stroke and congestive heart failure.
대표청구항
▼
1. A method of increasing oxygenation of an or organ or tissue in a patient in need thereof, comprising the steps of: transmitting a modulated signal into a patient's body at a location adjacent said at least one organ or tissue where oxygenation is to be increased, wherein said modulated signal inc
1. A method of increasing oxygenation of an or organ or tissue in a patient in need thereof, comprising the steps of: transmitting a modulated signal into a patient's body at a location adjacent said at least one organ or tissue where oxygenation is to be increased, wherein said modulated signal includes a low frequency sound and or vibration signal ranging from 0.5 Hz to 50 Hz combined with a modulating carrier frequency which ranges from 10 to 100,000 Hz;allowing demodulating of said modulated signal within said patient's body to yield a demodulated low frequency sound and or vibration signal that has a frequency comparable to a resonance frequency of said at least one internal organ or tissue of said patient; andperforming said transmitting and demodulating steps for a period sufficient to increase oxygenation of said organ or tissue. 2. The method of claim 1, wherein said method is used to treat or prevent a disorder selected from the group consisting of hemorrhagic shock, cardiogenic shock, congestive heart failure, cardiac arrest, septic shock, intestinal ischemia, myocardial ischemia, stroke, traumatic brain injury, sickle cell vaso-occlusive crisis, burns, compartment syndrome, and acute and chronic wounds, and osteoporosis and the treatment of hypothermia and hyperthermia. 3. The method of claim 1, wherein said step of transmitting is carried out by delivering said modulated signal through the patient's skin. 4. The method of claim 1, wherein said period in said steps of performing said transmitting and allowing demodulating is sufficient to cause vasodilation of microvasculature in said organ or tissue. 5. The method of claim 1, wherein said low frequency sound and or vibration signal has a frequency ranging from 5 Hz to 20 Hz. 6. The method of claim 1, wherein said modulating carrier frequency is in the range of 10 Hz to 100 Hz. 7. The method of claim 1, wherein said period in said steps of performing said transmitting and allowing demodulating is sufficient to treat or prevent tissue damage caused by low blood flow or ischemia. 8. The method of claim 7, wherein said low blood flow or ischemia is caused by an event selected from the group consisting of hemorrhagic shock, cardiogenic shock, congestive heart failure, cardiac arrest, septic shock, intestinal ischemia, myocardial ischemia, stroke, traumatic brain injury, sickle cell vaso-occlusive crisis, burns, compartment syndrome, and acute and chronic wounds, and aging. 9. The method of claim 1 wherein said step of transmitting is performed for specified period of time. 10. The method of claim 1 wherein said step of transmitting is performed continuously. 11. The method of claim 1 wherein said step of allowing demodulating is performed automatically within said patient's body. 12. The method of claim 1 wherein said low frequency sound and or vibration signal has a frequency ranging from 1 Hz to 50 Hz. 13. The method of claim 1 wherein said modulating carrier frequency is in the range of 40 Hz to 250 Hz. 14. The method claim 1, wherein said period in said steps of performing said transmitting and allowing demodulating is sufficient to treat immune or neurohormonal systems in a patient having an autonomic nervous system, or for enhancing thrombolysis or preventing secondary occlusion. 15. A system for oxygenation of a tissue or organ, comprising: a source of sound or vibratory stimulus which produces a low frequency sound or vibration signal ranging from 0.5 Hz to 50 Hz;a source of a carrier frequency signal wherein said carrier frequency signal ranges from 10 to 100,000 Hz;a modulator which combines said low frequency sound or vibration signal with said carrier frequency signal to produce a modulated signal;a transmitter for transmitting said modulated signal into a patient's body, said transmitter being configured for placement on or adjacent said patient's body so as to transmit said modulated signal into said patient's body; anda sensor for measuring oxygenation of said tissue or organ of said patient. 16. The system of claim 15, wherein said system is arranged as a closed loop which allows adjustment of frequencies to maximize and sustain tissue oxygenation. 17. The system of claim 15 wherein said carrier frequency signal is in the range of about 40-45 Hz.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.